<ul>
<li>此次銷售的總毛收益約為 26 億瑞士法郎，其中 EQT 獲得約 6.9 億瑞士法郎</li>
</ul>
<p>, /PRNewswire/ -- 根據之前的公告，EQT VIII（&#34; <strong>EQT</strong>&#34;）的一個關聯公司很高興地宣佈，已完成對 Galderma Group AG（SIX: GALD）（&#34; <strong>公司</strong>&#34;）的 2000 萬股股票（&#34; <strong>股票</strong>&#34;）的配售，獲得總毛收益約為 26 億瑞士法郎，採用加速賬簿建檔程序（&#34; <strong>配售</strong>&#34;）。</p>
<p>作為配售的一部分，EQT 獲得了約 6.9 億瑞士法郎的毛收益。配售於 2025 年 10 月 30 日完成。花旗全球市場、高盛國際、傑富瑞、美國美林國際、摩根士丹利和瑞士銀行擔任配售的聯合全球協調人和聯合賬簿管理人。</p>
<p><strong>聯繫方式</strong></p>
<p>EQT 新聞辦公室，[email protected]</p>
<p><em><strong>重要通知</strong></em></p>
<p><em>本新聞稿不構成（i）對 Galderma Group AG 或其任何關聯公司證券的出售要約或購買要約的徵求，也不構成瑞士金融服務法意義上的招股説明書；（ii）在美國或其他地方的證券出售要約。除非在美國證券交易委員會註冊或獲得註冊豁免，否則不得在美國提供或出售證券。本新聞稿中提到的任何證券在美國將不會進行公開發行。</em></p>
<p>此信息由 Cision 提供 http://news.cision.com</p>
<p>https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4259423</p>
<p>以下文件可供下載：</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>https://mb.cision.com/Main/87/4259423/3755401.pdf</td>
<td>新聞稿，EQT VIII，Galderma，30102025</td>
</tr>
</tbody>
</table>
<p>來源：EQT</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDMwJk5ld3NJdGVtSWQ9SU8xMTYwMSZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMzAxMjUyUFJfTkVXU19VU1BSX19fX19JTzExNjAx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDMwJk5ld3NJdGVtSWQ9SU8xMTYwMSZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMzAxMjUyUFJfTkVXU19VU1BSX19fX19JTzExNjAx"/></p>

摩根士丹利

高盛

<p>EQT 已完成對 Galderma Group AG 的 2000 萬股股票的出售，產生了約 26 億瑞士法郎的總收益。EQT 從此次配售中獲得了約 6.9 億瑞士法郎，該交易於 2025 年 10 月 30 日完成。此次交易由花旗集團、高盛、傑富瑞、美林證券、摩根士丹利和瑞士銀行作為聯合全球協調人和賬簿管理人進行促成。本公告不構成在美國或其他地方出售或招攬證券的要約</p>

<ul>
<li>The sale resulted in aggregate gross proceeds of c. CHF 2.6 billion, of which EQT received c. CHF 690 million</li>
</ul>
<div class="lb-trans"><ul>
<li>此次銷售的總毛收益約為 26 億瑞士法郎，其中 EQT 獲得約 6.9 億瑞士法郎</li>
</ul>
</div><p>, /PRNewswire/ -- Further to previous announcements, an affiliate of the funds known as EQT VIII (&#34; <strong>EQT</strong>&#34;) is pleased to announce the completion of the placement of 20 million shares in Galderma Group AG (SIX: GALD) (the &#34; <strong>Company</strong>&#34;) (the &#34; <strong>Shares</strong>&#34;) for aggregate gross proceeds of c. CHF 2.6 billion via an accelerated bookbuilding process (the &#34; <strong>Placement</strong>&#34;).</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 根據之前的公告，EQT VIII（&#34; <strong>EQT</strong>&#34;）的一個關聯公司很高興地宣佈，已完成對 Galderma Group AG（SIX: GALD）（&#34; <strong>公司</strong>&#34;）的 2000 萬股股票（&#34; <strong>股票</strong>&#34;）的配售，獲得總毛收益約為 26 億瑞士法郎，採用加速賬簿建檔程序（&#34; <strong>配售</strong>&#34;）。</p>
</div><p>As part of the Placement, EQT received gross proceeds of c. CHF 690 million. The Placement was completed on 30 October 2025. Citigroup Global Markets, Goldman Sachs International, Jefferies, Merrill Lynch International, Morgan Stanley and UBS acted as joint global coordinators and joint bookrunners for the Placement.</p>
<div class="lb-trans"><p>作為配售的一部分，EQT 獲得了約 6.9 億瑞士法郎的毛收益。配售於 2025 年 10 月 30 日完成。花旗全球市場、高盛國際、傑富瑞、美國美林國際、摩根士丹利和瑞士銀行擔任配售的聯合全球協調人和聯合賬簿管理人。</p>
</div><p><strong>Contact</strong></p>
<div class="lb-trans"><p><strong>聯繫方式</strong></p>
</div><p>EQT Press Office, [email protected]</p>
<div class="lb-trans"><p>EQT 新聞辦公室，[email protected]</p>
</div><p><em><strong>Important notice</strong></em></p>
<div class="lb-trans"><p><em><strong>重要通知</strong></em></p>
</div><p><em>This press release does not constitute (i) an offer to sell or a solicitation of an offer to buy any securities of Galderma Group AG or any of its affiliates and it does not constitute a prospectus within the meaning of the Swiss Financial Services Act or (ii) an offer of securities for sale in the United States or elsewhere. Securities may not be offered or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration. There will be no public offering of any of the securities mentioned in this press release in the United States.</em></p>
<div class="lb-trans"><p><em>本新聞稿不構成（i）對 Galderma Group AG 或其任何關聯公司證券的出售要約或購買要約的徵求，也不構成瑞士金融服務法意義上的招股説明書；（ii）在美國或其他地方的證券出售要約。除非在美國證券交易委員會註冊或獲得註冊豁免，否則不得在美國提供或出售證券。本新聞稿中提到的任何證券在美國將不會進行公開發行。</em></p>
</div><p>This information was brought to you by Cision http://news.cision.com</p>
<div class="lb-trans"><p>此信息由 Cision 提供 http://news.cision.com</p>
</div><p>https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4259423</p>
<div class="lb-trans"><p>https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4259423</p>
</div><p>The following files are available for download:</p>
<div class="lb-trans"><p>以下文件可供下載：</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>https://mb.cision.com/Main/87/4259423/3755401.pdf</td>
<td>Press Release, EQT VIII, Galderma, 30102025</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>https://mb.cision.com/Main/87/4259423/3755401.pdf</td>
<td>新聞稿，EQT VIII，Galderma，30102025</td>
</tr>
</tbody>
</table>
</div><p>SOURCE EQT</p>
<div class="lb-trans"><p>來源：EQT</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDMwJk5ld3NJdGVtSWQ9SU8xMTYwMSZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMzAxMjUyUFJfTkVXU19VU1BSX19fX19JTzExNjAx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=IO11601&amp;Transmission_Id=202510301252PR_NEWS_USPR_____IO11601&amp;DateId=20251030"/></p>

EQT 完成了出售 Galderma Group AG 股份的交易